Buch, Englisch, 364 Seiten, Format (B × H): 163 mm x 224 mm, Gewicht: 658 g
Challenges, Case Studies and Lessons Learned from Medicine Price Control
Buch, Englisch, 364 Seiten, Format (B × H): 163 mm x 224 mm, Gewicht: 658 g
ISBN: 978-0-443-23518-4
Verlag: Elsevier Science
Provides readers with a framework to understand and analyze several medicine pricing policies. Through case studies from countries across geographies and income tiers, this book explores the challenges and opportunities related to price control experiences. Studying global policies this book discusses approaches, strategies, and the underlying pharmaceutical pricing practices used to provide advice for formulating highly effective policies. Alongside the cases, this book covers appropriate research methods for pricing analysis, the essential components of pricing policy, data quality, and the generic structure of a pharmaceutical pricing policy.
Autoren/Hrsg.
Fachgebiete
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Marketing
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
Weitere Infos & Material
1. Pharmaceutical pricing policies: Introduction, key concepts and evidence synthesis
2. Analysis of anti-retroviral medicines prices: A review of literature
3. Evidence on pharmaceutical pricing policies in Europe
4. Pharmaceutical pricing policies in Italy
5. Pharmaceutical pricing policies in Indonesia
6. Canada’s medicine pricing policies: implementation strategies and models
7. Pharmaceutical pricing policies in Thailand
8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis
9. Strategies for medicine pricing in Southeast Asia
10. Pharmaceutical pricing policies in Syria
11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines
12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement
13. Pharmaceutical pricing policies in Spain
14. Pharmaceutical pricing strategies in the US
15. Money matters - How financing for medicines R&D affects medicines, and what to do about it
16. The role of Civil Society Organizations ensuring price transparency
17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil
18. Pharmaceutical pricing policies in Greece
